Related Experiment Videos

A cluster randomised controlled trial of the effect of a treatment algorithm for hypertension in patients with type 2

Charlotte Bebb1, Denise Kendrick, Carol Coupland

  • 1Renal Unit, City Hospital Campus, Nottingham University Hospitals, Hucknall Road, Nottingham. charlotte.bebb@nuh.nhs.uk

Insights

A blood pressure (BP) treatment algorithm did not improve BP control in type 2 diabetes patients in primary care. Increased monitoring and medication did not lead to better outcomes, suggesting specialist care improvements may not transfer to primary settings.

Area of Science:

  • Cardiology
  • Endocrinology
  • Primary Care Medicine

Background:

  • Effective blood pressure (BP) control is crucial for reducing complications in type 2 diabetes patients.
  • Many individuals with type 2 diabetes struggle to achieve recommended BP targets.
  • Current hypertension management guidelines advocate for escalating antihypertensive medications, but their effectiveness in routine primary care is not well-established.

Purpose of the Study:

  • To assess the efficacy of a structured BP treatment algorithm for managing hypertension in primary care patients with type 2 diabetes.
  • To compare the outcomes of an algorithm-guided approach versus usual care in this patient population.

Main Methods:

  • A cluster randomized controlled trial involving 1534 patients with type 2 diabetes across 42 UK primary care practices.
  • Practices were randomized to either usual care or an intervention group utilizing a BP treatment algorithm.
  • The algorithm guided practice nurses and GPs in escalating antihypertensive therapy to achieve a target BP of 140/80 mmHg.

Main Results:

  • No significant difference in the proportion of patients achieving target BP at 1 year between the intervention and control groups (36.6% vs. 34.3%, P = 0.27).
  • Mean systolic and diastolic BP levels were identical in both groups (143/78 mmHg).
  • The intervention group showed a higher rate of BP-related primary care consultations (rate ratio = 1.55, P<0.001) and potentially higher medication doses without a significant increase in drug variety.

Conclusions:

  • Implementing a BP treatment algorithm in primary care did not enhance BP control for patients with type 2 diabetes, despite increased monitoring and medication adjustments.
  • Findings suggest that treatment improvements observed in specialist nurse-led secondary care settings may not be directly transferable to primary care environments for this population.
Abstract

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...